Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07868926
PHASE1

Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose

Sponsor: Vertex Pharmaceuticals Incorporated

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of VX-407 following a single oral dose.

Official title: A Phase 1, Open-Label, Mass Balance Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 Following Single Oral Administration in Healthy Subjects

Key Details

Gender

MALE

Age Range

19 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2026-10-19

Completion Date

2026-12-15

Last Updated

2026-10-09

Healthy Volunteers

Yes

Interventions

DRUG

14C-VX-407

Solution for Oral Administration.